2025-11-05
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia – And A Range Of Celebs From Athletes To Scientists Are Customers
When it comes to brain health, Jupiter Neurosciences Inc. (NASDAQ:JUNS) knows a thing or two about it. After all, the clinical-stage pharmaceutical company developing JOTROLTM, an enhanced orally administered resveratrol formulation known for its antioxidant and anti-inflammatory effects, has developed NugeviaTM, a direct-to-consumer longevity product line, aimed at improving mitochondrial support, mental clarity and “beauty from within.”At the center of this consumer push into supplements, and what is expected to account for about 60% of the company's sales by volume, is cognitive health – with the key driver being the company's Nugevia MND offering, a scientifically formulated supplement designed to protect and enhance cognitive function and support overall brain health. "Brain health is central to Jupiter's DNA as a neuroscience company, and consumer awareness in this area is accelerating rapidly," said a Jupiter Neurosciences spokesperson. "Our Nugevia MND formulation directly builds on our pharmaceutical expertise in neuroinflammation and CNS function, making it the most natural bridge between our clinical work and consumer wellness line. MND reflects the growing demand for cognitive support driven by aging populations and proactive consumers seeking mental clarity, focus and resilience."Brain Health On Everyone’s Mind There is a growing demand for cognitive support among aging populations around the globe. As the population ages and people live longer, there is an increasing demand to improve mental clarity, concentration and overall brain health. People are increasingly aware that living longer also involves efforts to stay mentally sharp and emotionally engaged. The brain drives every aspect of performance, from focus and ...Full story available on Benzinga.com